New MRI scan to track glioblastoma growth during treatment
Part of Cancer clinical trials.
This study is testing a new type of MRI called APTw-CEST to see if it can better detect tumor progression in people with glioblastoma. It may help doctors monitor your tumor more accurately during radiation or chemoradiation therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed or suspected glioblastoma (a type of brain tumor).
- You are scheduled to start radiation therapy or combined chemotherapy and radiation.
- You are at least 18 years old.
- You can understand and sign a consent form.
- You will already be having standard MRI scans as part of your care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This trial is testing a new way to find and remove glioblastoma brain tumors using a special MRI scan. It may help doctors remove more of the tumor safely during surgery.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This study uses special MRI techniques to better understand how a high-grade brain tumor spreads into nearby brain tissue. The information may help doctors plan safer and more effective tumor removal.
This trial tests a special MRI technique to guide surgeons in removing more of the brain tumor during surgery. The goal is to help people with glioblastoma live longer.
This study uses repeated MRI scans during radiation treatment to see how tumors change. It may help doctors adjust treatment and improve outcomes for many types of cancer.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.